Send us Fan Mail

A cancer diagnosis doesn't have to feel like a death sentence. The science is advancing faster than most people realize, and what patients know about their own diagnosis can change everything.

Dr. Sanjay Juneja, TheOncDoc joins host John Driscoll to discuss why cancer is increasingly a manageable disease, how patient empowerment and early detection are shifting outcomes, and what everyone can do right now to reduce their cancer risk.

🎙️⚕️ABOUT SANJAY JUNEJA, MD
Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine. Garnering over 750k followers and 50 million views on social media, Dr. Juneja’s unique ability to simplify complex topics has earned him global acclaim. His debut podcast, Target Cancer: Podcast, amassed 4+ million downloads in over 120 countries within just two years, setting the stage for his current AI-focused series featuring world-renowned guests.

Dr. Juneja’s accolades include being named Targeted Oncology’s inaugural 2024 Oncology Icon, an invitation to the White House’s 2023 Healthcare Leaders in Social Media Roundtable, and recognition as a 40 Under 40 honoree and one of the Capital Region’s Top 500 Most Influential Leaders for three consecutive years. His insights have been featured in The Washington Post, WIRED, Bloomberg, and PBS.

In addition to founding TensorBlack, an educational platform specializing in AI applications in oncology, Dr. Juneja serves as Vice President of Clinical AI Operations at Tempus AI and a contributing writer + Technology council for Forbes.  He is credentialed by Harvard Medical School’s inaugural AI in Healthcare: From Strategies to Implementation Executive Education, and an Editorial Board Member for the peer-reviewed journal AI in Precision Oncology.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

Why does it take five years to diagnose a child with a genetic disease when the answer is available in 48 hours?

In this clip from our episode “How Genomics Is Transforming Rare Disease Care”, host John Driscoll and guest Katherine Stueland, CEO of GeneDx, expose one of the most frustrating gaps in pediatric medicine today.

🎙️⚕️ABOUT KATHERINE STUELAND
Katherine Stueland has dedicated her career to transforming healthcare by leading patient-centric businesses. Her career has spanned supporting the FDA approval of several rare disease therapeutics, the first protease inhibitor for HIV/AIDS and the first cancer immunotherapy, all in partnership with the powerful voices of patient advocates. Katherine has been a central figure in moving healthcare forward by integrating genomic information to enhance the accuracy and effectiveness of diagnosing cancer and rare diseases.

In June 2021, Katherine was named President and CEO of GeneDx (Nasdaq: WGS), a company that emerged from the National Institutes of Health and today is transforming healthcare through genomic insights with a mission to empower everyone to live their healthiest lives through the power of genomics. GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and drive drug discovery. Since joining GeneDx, she focused the business on its industry-leading exome and genome testing and interpretation products, fueled by GeneDx Infinity™ the world’s largest genomic rare disease data set. Under Katherine’s leadership, GeneDx has nearly tripled its sequencing capacity, completing over 1 million exomes and genomes while achieving profitability.

Recognized for these achievements, Katherine was named the 2026 TIME100 Health list, honoring the world’s most influential health leaders. In 2025 she was also named to CNBC Changemakers: Women Transforming Business List, and GeneDx was named of Fast Company Most Innovative Companies. In 2023, Fierce Pharma recognized Katherine as one of the most influential people in biotech.

Katherine serves on the Board of Directors for the American Clinical Laboratory Association (ACLA), the national trade association for leading laboratories, advancing policies that improve patient outcomes, expand access to high-quality diagnostics, and enable personalized care. She also serves on the JED Foundation Leadership Council, a nonprofit organization that works to prevent suicide and protect the emotional health of young adults and teens as part of her lifetime commitment to help improve mental health. Katherine graduated from Miami University in Oxford, Ohio, with a bachelor’s degree in science and English literature.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

One in six children has a developmental delay, and it takes an average of five years to get a diagnosis for a genetic disease. But it doesn't have to. The technology to get answers in 48 hours already exists.

Katherine Stueland, CEO, GeneDx joins host John Driscoll to discuss why rare genetic diseases are far more common than most people realize, how whole genome sequencing is transforming pediatric care, and what it will take to bring precision medicine to every child who needs it.

🎙️⚕️ABOUT KATHERINE STUELAND
Katherine Stueland has dedicated her career to transforming healthcare by leading patient-centric businesses. Her career has spanned supporting the FDA approval of several rare disease therapeutics, the first protease inhibitor for HIV/AIDS and the first cancer immunotherapy, all in partnership with the powerful voices of patient advocates. Katherine has been a central figure in moving healthcare forward by integrating genomic information to enhance the accuracy and effectiveness of diagnosing cancer and rare diseases.

In June 2021, Katherine was named President and CEO of GeneDx (Nasdaq: WGS), a company that emerged from the National Institutes of Health and today is transforming healthcare through genomic insights with a mission to empower everyone to live their healthiest lives through the power of genomics. GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and drive drug discovery. Since joining GeneDx, she focused the business on its industry-leading exome and genome testing and interpretation products, fueled by GeneDx Infinity™ the world’s largest genomic rare disease data set. Under Katherine’s leadership, GeneDx has nearly tripled its sequencing capacity, completing over 1 million exomes and genomes while achieving profitability.

Recognized for these achievements, Katherine was named the 2026 TIME100 Health list, honoring the world’s most influential health leaders. In 2025 she was also named to CNBC Changemakers: Women Transforming Business List, and GeneDx was named of Fast Company Most Innovative Companies. In 2023, Fierce Pharma recognized Katherine as one of the most influential people in biotech.

Katherine serves on the Board of Directors for the American Clinical Laboratory Association (ACLA), the national trade association for leading laboratories, advancing policies that improve patient outcomes, expand access to high-quality diagnostics, and enable personalized care. She also serves on the JED Foundation Leadership Council, a nonprofit organization that works to prevent suicide and protect the emotional health of young adults and teens as part of her lifetime commitment to help improve mental health. Katherine graduated from Miami University in Oxford, Ohio, with a bachelor’s degree in science and English literature.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

What if food worked better than medication for managing diabetes?

In this clip from our episode “Food As Medicine: From Trend to Treatment”, CareTalk host John Driscoll and guest Spencer Pratt, Chief Growth Officer at NourishedRx, share the clinical data behind their food as medicine approach to diabetes care.

🎙️⚕️ABOUT SPENCER PRATT
Spencer is Chief Growth Officer at NourishedRx. He is a leader in developing innovative frameworks and solutions for addressing social drivers of health, health equity, and population health.

Prior to joining NourishedRx, Spencer held leadership roles at Unite Us and Carrot Health and established a consumer insights solution at Optum. He takes an innovative and customer-centric approach to ensure value creation and exceptional experience for healthcare organizations and members.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

Food as medicine is moving from buzzword to real healthcare strategy.

In this CareTalk episode, Spencer Pratt, Chief Growth Officer of NourishedRx, explains why nutrition is finally getting the policy, payer, and consumer support needed to impact chronic disease at scale.

🎙️⚕️ABOUT SPENCER PRATT
Spencer is Chief Growth Officer at NourishedRx. He is a leader in developing innovative frameworks and solutions for addressing social drivers of health, health equity, and population health.

Prior to joining NourishedRx, Spencer held leadership roles at Unite Us and Carrot Health and established a consumer insights solution at Optum. He takes an innovative and customer-centric approach to ensure value creation and exceptional experience for healthcare organizations and members.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

Is American primary care already past the point of no return?

In this clip from our episode “Why US Healthcare is Fundamentally Broken”, host David E. Williams and guest Zeev Neuwirth, Head of Strategic Partnerships at Rezilient Health, confront a stark reality about where primary care spending stands today.

🎙️⚕️ABOUT ZEEV NEUWIRTH, MD
For the past 30 years, his work has been centered around humanizing healthcare, making it more affordable, accessible, equitable, and effective for all people. Strategically, his approach is to leverage digital technologies, data analytics, and consumer-centric business models to create sustainable, scalable solutions. He believes it is critical that we drive towards an integrated healthcare delivery system built upon preventive primary & population-based healthcare.

In addition to his industry work, he has published two Amazon best-selling books - "Reframing Healthcare: A Roadmap For Creating Disruptive Change" and "Beyond the Walls: Megatrends, Movements, and Market Disruptors Transforming American Healthcare." His podcast, "Creating a New Healthcare" is now in its ninth year with over 200 posted episodes. These efforts are all in service of reorienting the way individuals and organizations think about healthcare, and redirecting resources and efforts to catalyze movement towards a system that delivers the healthcare and health outcomes that people want and need.

🎙️⚕️ABOUT HEALTH BIZ PODCAST
HealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

Primary care is on life support. Administrative burden is crushing physicians, employer healthcare is broken, and decades of reform efforts have barely moved the needle. So what does real transformation actually look like?

Zeev Neuwirth, Head of Strategic Partnerships, Rezilient Health joins host David E. Williams to discuss why the American healthcare system keeps failing despite enormous resources, what direct primary care and employer contracting can do differently, and why GLP-1s without lifestyle medicine may be a costly mistake.

🎙️⚕️ABOUT ZEEV NEUWIRTH, MD
For the past 30 years, his work has been centered around humanizing healthcare, making it more affordable, accessible, equitable, and effective for all people. Strategically, his approach is to leverage digital technologies, data analytics, and consumer-centric business models to create sustainable, scalable solutions. He believes it is critical that we drive towards an integrated healthcare delivery system built upon preventive primary & population-based healthcare.

In addition to his industry work, he has published two Amazon best-selling books - "Reframing Healthcare: A Roadmap For Creating Disruptive Change" and "Beyond the Walls: Megatrends, Movements, and Market Disruptors Transforming American Healthcare." His podcast, "Creating a New Healthcare" is now in its ninth year with over 200 posted episodes. These efforts are all in service of reorienting the way individuals and organizations think about healthcare, and redirecting resources and efforts to catalyze movement towards a system that delivers the healthcare and health outcomes that people want and need.

🎙️⚕️ABOUT HEALTH BIZ PODCAST
HealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

Is this AI moment in healthcare really different from all the hype that came before?

In this clip from our episode “A Brief History of AI in Healthcare”, Lekan Wang, Partner at JSL Health Capital, makes his case for why the data is finally backing up the optimism.

Check out the full episode here

🎙️⚕️ABOUT LEKAN WANG
Lekan Wang is a partner at JSL Health Capital, an AI first healthcare investment fund that is joining with some of the cutting edge companies that are leveraging technology in advancing healthcare and  hopefully creating better outcomes at lower costs.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

Every year, millions of Americans end up in emergency rooms and hospital beds for conditions that could be treated just as well, and far more safely,in their own homes. So why does care still default to the most expensive, most disruptive setting possible? And who's actually doing something about it?

Lon Hecht, CEO, Care2U joins host David Williams, President of Health Business Group to discuss bringing high-acuity care into the home, why hospital at home has struggled to scale, and how payers and providers are finally starting to align around a better model.

🎙️⚕️ABOUT CARE2U
Care2U delivers emergency and hospital-level care directly to patients in their homes, bringing the expertise of the hospital without the stress, cost, or risk of a hospital visit. Patients receive faster care in a familiar environment, while insurers and risk-bearing providers benefit from better outcomes at a fraction of the cost.

Each visit is powered by a dual-provider model: a clinician at the bedside paired with a physician via telehealth, working together to deliver thorough, personalized care without delay.

Care2U partners with payers and health systems to build a scalable model that improves outcomes, lowers costs, and reimagines how acute care is delivered, bringing high-acuity medicine directly to where patients need it most: home.

Please reach out to Lon Hecht at [email protected] if you are interested in learning more or working together.

You can also check out their website here

🎙️⚕️ABOUT LON HECHT
Lon Hecht is a seasoned healthcare executive with over 25 years of experience leading transformative growth. He joined Care2U as Chief Growth Officer in 2023 and became CEO in 2024, reflecting his strategic vision and results-driven leadership. Previously, Lon was SVP of Growth at Optum Home and Community Care, where he helped integrate and scale innovative healthcare models, including naviHealth, Landmark, Prospero, and Optum at Home. His leadership portfolio includes roles as Chief Commercial Officer at Utilize Health, VP of Payor and Provider Markets at Teladoc, Founder and CEO of QuickSeeMD, and VP of Sales at eviCore. Known for delivering exponential growth and building high-performing teams, Lon is a recognized leader in value-based care. He combines entrepreneurial drive with operational expertise and a strong network across payor and provider markets. Lon holds a B.S. in Marketing from West Chester University of Pennsylvania and resides with his family on the Jersey Shore.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan Mail

AI has been promising to transform healthcare for decades. So what's actually different this time? From Palantir's early data integration work to the frontier of AI-driven drug discovery, the evidence for optimism is growing and so is the urgency to get it right.

Lekan Wang, Partner, JSL Health Capital joins host John Driscoll to discuss the real history of AI, where it's already delivering results in healthcare, and what investors are betting on next.

🎙️⚕️ABOUT LEKAN WANG
Lekan Wang is a partner at JSL Health Capital, an AI first healthcare investment fund that is joining with some of the cutting edge companies that are leveraging technology in advancing healthcare and  hopefully creating better outcomes at lower costs.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.